155 related articles for article (PubMed ID: 24854571)
1. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells.
Wang Y; Yang C; Xie WL; Zhao YW; Li ZM; Sun WJ; Li LZ
Phytomedicine; 2014; 21(8-9):1032-6. PubMed ID: 24854571
[TBL] [Abstract][Full Text] [Related]
2. LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells.
Wang Y; Li LZ; Zhang YL; Zhu YQ; Wu J; Sun WJ
Mol Cell Endocrinol; 2011 Apr; 337(1-2):43-51. PubMed ID: 21291955
[TBL] [Abstract][Full Text] [Related]
3. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells.
Sun J; Sun WJ; Li ZY; Li L; Wang Y; Zhao Y; Wang C; Yu LR; Li LZ; Zhang YL
Int Immunopharmacol; 2016 Nov; 40():32-40. PubMed ID: 27576059
[TBL] [Abstract][Full Text] [Related]
4. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation.
Wang Y; Wang WL; Xie WL; Li LZ; Sun J; Sun WJ; Gong HY
Phytomedicine; 2013 Jul; 20(10):787-96. PubMed ID: 23639192
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica.
Tiyasatkulkovit W; Charoenphandhu N; Wongdee K; Thongbunchoo J; Krishnamra N; Malaivijitnond S
Phytomedicine; 2012 Oct; 19(13):1147-55. PubMed ID: 22951392
[TBL] [Abstract][Full Text] [Related]
6. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
7. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
[TBL] [Abstract][Full Text] [Related]
8. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Mok SK; Chen WF; Lai WP; Leung PC; Wang XL; Yao XS; Wong MS
Br J Pharmacol; 2010 Feb; 159(4):939-49. PubMed ID: 20128811
[TBL] [Abstract][Full Text] [Related]
9. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Li H; Chen B; Pang G; Chen J; Xie J; Huang H
Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
[TBL] [Abstract][Full Text] [Related]
10. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice.
Sheu SY; Tsai CC; Sun JS; Chen MH; Liu MH; Sun MG
Chin Med J (Engl); 2012 Oct; 125(20):3646-53. PubMed ID: 23075718
[TBL] [Abstract][Full Text] [Related]
12. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway.
Wang YD; Tao MF; Wang L; Cheng WW; Wan XP
Horm Metab Res; 2012 Jun; 44(7):494-500. PubMed ID: 22556124
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
[TBL] [Abstract][Full Text] [Related]
15. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation.
Park K; Ju WC; Yeo JH; Kim JY; Seo HS; Uchida Y; Cho Y
Int J Mol Med; 2014 Jan; 33(1):178-84. PubMed ID: 24248634
[TBL] [Abstract][Full Text] [Related]
16. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
17. Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation.
Jin X; Sun J; Yu B; Wang Y; Sun WJ; Yang J; Huang SH; Xie WL
Nutr Res; 2017 Jun; 42():20-30. PubMed ID: 28633868
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.
Viereck V; Gründker C; Blaschke S; Niederkleine B; Siggelkow H; Frosch KH; Raddatz D; Emons G; Hofbauer LC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4206-13. PubMed ID: 12970288
[TBL] [Abstract][Full Text] [Related]
19. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
[TBL] [Abstract][Full Text] [Related]
20. Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.
Liang L; Yu JF; Wang Y; Ding Y
J Periodontol; 2008 Sep; 79(9):1745-51. PubMed ID: 18771377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
